The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’-Reference-Cited by-同舟云学术

The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’

Published:2023-01 Issue:1 Volume:29 Page:1-3
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Belkin Ana,Leibowitz Avshalom,Shargian Liat,Yahav Dafna

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports;Deveci;Case Rep Med (Baltimore),2021

2. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies;Lee;Cancer Discov,2022

3. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?;Gousseff;J Infect,2020

4. Vaccination for SARS-CoV-2 in hematological patients;Riccardi;Acta Haematol,2022

5. Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection in patients treated with anti-CD20 monoclonal antibodies;Calderón-Parra;Clin Infect Dis,2022

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report;Journal of Infection and Public Health;2024-10

2. Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.;Clinical Microbiology and Infection;2024-09

3. ‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’: author's response;Clinical Microbiology and Infection;2024-09

4. Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management;Clinical Microbiology and Infection;2024-08

5. COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics;Transplantation and Cellular Therapy;2024-08